The Indian pharmaceutical industry has the potential to deliver 100 new drugs for global markets by 2047, driven by enhanced research and development (R&D) efforts, Zydus Lifesciences ...

As of the latest exchange rate (approximately Rs 83 per USD), $3.1 billion is approximately: Rs 25,730 crore (Rs 25,730,00,00 ...

Let’s delve into the lives of his three esteemed Mukesh Ambani and Nita Ambani's samdhis who are part of India’s richest ...

New Delhi The Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced ...

Pankaj R Patel, Chairman of Zydus Lifesciences, envisions India delivering 100 new drugs by 2047, highlighting the importance of research, innovation, and capable human resources. He addressed myths ...

Indian markets closed lower on Thursday, dragged by banking and auto stocks, while U.S. tariff concerns pressured sentiment.

Retail and banking stocks rose 0.5 per cent and 0.7 per cent, respectively. NEW DELHI: BSE(Rs. 2851.95 crore), HDFC Bank(Rs.

The Nifty Pharma index closed on a negative note on Thursday. Shares of Ipca Laboratories Ltd.(up 1.97 per cent), Gland ...

Indian drugmakers prepare for US tariffs, emphasizing role in providing affordable medicines while navigating potential impacts and uncertainties.

Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...